Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Acta Orthop ; 89(3): 272-277, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29493328

ABSTRACT

Background and purpose - The use of local infiltration anesthesia (LIA) has become one of the cornerstones of rapid recovery protocols in total knee arthroplasty patients during the past decade. In total hip arthroplasty (THR), however, the study results are more variable and LIA has therefore not yet been generally accepted. There is no consensus on which structure should be infiltrated and the cutaneous nerves are generally neglected. Hence, we hypothesized a pain-reducing effect of specifically blocking these nerves. Patients and methods - We performed a single-center randomized placebo-controlled trial in 162 subjects to evaluate the infiltration of the lateral cutaneous femoral and subcostal nerve with ropivacaine in patients undergoing total hip arthroplasty via a straight lateral approach. The primary endpoint was pain at rest after 24 hours. Patients were followed up to 6 weeks postoperatively. Results - After correction for multiple testing, no statistically significant differences in pain scores were found between the ropivacaine compared with the placebo group after surgery. In addition, no differences were observed in the use of escape pain medication, complications, and the length of hospital stay. Interpretation - We found no clinically meaningful differences in pain scores between placebo and ropivacaine patients in the postoperative period after THA performed via a straight lateral approach under spinal anesthesia and a multimodal pain regimen. Moreover, our primary endpoint, pain reduction after 24 hours, was not met. Further research should focus on the composition and volume of the LIA suspension, the optimal localization of the infiltration, and should be evaluated for every surgical approach separately.


Subject(s)
Anesthetics, Local/therapeutic use , Arthroplasty, Replacement, Hip/adverse effects , Nerve Block/methods , Osteoarthritis, Hip/surgery , Pain, Postoperative/prevention & control , Ropivacaine/therapeutic use , Aged , Anesthesia, Local , Anesthesia, Spinal , Female , Humans , Male , Middle Aged , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology
2.
Hip Int ; 28(3): 330-335, 2018 May.
Article in English | MEDLINE | ID: mdl-29048689

ABSTRACT

INTRODUCTION: The purpose of the present study is to report the long-term clinical results of an uncemented total hip arthroplasty (THA) using a Metasul metal-on-metal (MoM) 28-mm bearing and to evaluate the long-term serum cobalt levels. METHODS: At an average of 12.6 years following primary THA, we retrospectively reviewed the clinical results of the first 116 consecutive patients (128 THAs) in our institution who underwent 28-mm Metasul MoM THA. Of the 78 patients who were able to visit our outpatient clinic, serum cobalt levels were evaluated. RESULTS: The overall survival rate of the cohort was 96.1% (95% confidence interval [CI], 93.2-99.6), 12.6 years (95% CI, 12.3-12.7 years) following surgery. 3 patients had undergone revision due to aseptic loosening of the stem and 2 patients sustained a periprosthetic fracture. The average modified Harris Hip Score was 90 (72-97) and the average Oxford Hip Score was 56 (48-60), representing both excellent outcome scores. The average serum cobalt of the entire cohort was 20.1 nmol/L (range 8.5-227.7 nmol/L). Serum cobalt levels of patients with a bilateral MoM THA were significantly higher (35.0 nmol/l, p<0.01). No relation between serum cobalt levels, subjective outcome, radiolucent lines on radiographs and survivorship of the implant was noted. CONCLUSIONS: Long-term results of the metasul MoM bearing articulation in THA seem to be excellent, although cobalt serum levels should be monitored closely.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Hip Prosthesis , Metal-on-Metal Joint Prostheses , Periprosthetic Fractures/epidemiology , Prosthesis Failure , Adult , Aged , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Hip/methods , Cobalt/blood , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Metals , Middle Aged , Prosthesis Design , Radiography , Reoperation , Retrospective Studies , Time Factors , Treatment Outcome
3.
Foot Ankle Surg ; 18(3): 160-3, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22857957

ABSTRACT

BACKGROUND: We report a gastrocnemius lengthening in neurologically healthy children, whose gastrocnemius equinus could not be corrected non-operatively. METHODS: Fifty-five children with an equinus contracture were included in this study. Ninety-seven operations were performed in these patients. The mean age was 11.5 years [6-16] and sixty percent of the patients were male. After 12 weeks we measured dorsiflexion post-surgery and after one year all parents of patients were telephoned and asked about their satisfaction with the result of the surgical treatment. Persistence of pre-operative complaints and complications were evaluated. RESULTS: Ankle dorsiflexion significantly improved by more than 11° post-surgery compared with preoperative (p=0.01). The mean satisfaction was 8.0 [4-10] on a 10-point VAS scale. Except one complication of ankle fracture during surgery, no other clinically relevant complications were observed. At follow up 50% of the patients have no complaints, 47% reported an improvement but some persisting complaints and 3% of the patients report no improvement. CONCLUSION: Percutaneous muscular gastrocnemius lengthening can be used to correct gastrocnemius equinus in otherwise healthy children, who have not benefited from prior nonsurgical treatment.


Subject(s)
Equinus Deformity/surgery , Muscle, Skeletal/surgery , Adolescent , Child , Female , Humans , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...